Currently, Health Canada has approved Microbiota Transplant (FMT) for use only in cases of C. difficile infection. Health Canada's last revision on FMT is outdated considering recent publications. Trials have revealed findings that FMT can be safe and beneficial for those looking to lessen symptoms related to diagnosis such as Autism or IBD.

FMT may not be a cure-all, but those who desire it deserve safe access in order to improve their health potential. Instead, as things stand, it has been decided that that patients are not responsible enough to make their own decisions regarding FMT use and their bodies. The truly motivated are seeking out their own donors and doing DIY versions, which do have the potential to be dangerous if screening and health practices are not taken seriously.

We can look to private clinics in the UK and Australia to see examples of safe screening and use of FMT. These clinics have operated for a decade or more without death or other severe incidents.

Health Canada needs to reconsider their current stance on FMT with the inclusion of recent publications as well as citizen input. Let’s follow the lead of the UK and make FMT a prescribed medicine for conditions besides C. Difficile.

 

See research:

Borody TJ, Campbell J. (2011, December) Fecal Microbiota Transplantation: Current Status and Future Directions. Expert Review of Gastroenterology and Hepatology; 5(6): 653-655.

Borody, Thomas et al (2003) Treatment of Ulcerative Colitis using Fecal Bacteriotherapy. Journal of Clinical Gastroenterology: Vol 37. (1)
Paul E. Carlson. Regulatory Considerations for Fecal Microbiota Transplantation Products. Cell Host & Microbe, 2020; 27 (2): 173 DOI: 10.1016/j.chom.2020.01.018
 
Paul Moayedi et al (2015) FMT Induces Remission in Patients with Active UC in a Randomized Controlled Trial. Gastroenterology. Vol 149. Issue 1.

Jasmohan Bajaj et al (2017) FMT from rational stool donor improves hepatic encephalopathy: randomized clinical trial. Hepatology.

Byron Vaughn et al (2016) Increased intestinal microbial diversity following FMT for Active Crohns Disease. Inflammatory Bowel Diseases. Vol 22.

James Adams et al (2019) Long term benefit of Microbiota transfer therapy in Autism symptoms and gut microbiota. Scientific Reports.

Julian Kenyon et al (2019) A retrospective outcome study of 42 patients with CFS, 30 of whom had IBS. Half treated with oral approaches and half with FMT. Human Microbiome Journal. Vol 13.

Johnsen PH et al. (2018) FMT versus placebo for moderate to severe IBS: double blind randomized parallel group single centre trial. Lancet Gastroenterol Hepatol. Vol 3

MF Sun et al (2018) Neuroprotective effects of FMT on MPTP induced Parkinsons disease mice: Gut microbiota, glial reaction and TLR4/TNF a signaling pathway. Brain Behavior Immunity.

FMT to save Koalas: https://www.sciencedaily.com/releases/2019/08/190820200449.htm

Film Director Saffran Cassaday speaks to how FMT saved her life:
https://designershitdocumentary.com/wellness-for-life-radiotalks-to-saffron-cassaday-about-fecal-transplants/

FMT for Pets: https://www.animalbiome.com/fecal-microbiota-transplant-capsules-aka-poo-pills